10 employees
Bioherent is a provider of diagnostic test for drug allergies.
2021
$1.6M
from 3 investors over 3 rounds
Bioherent raised $1.6M on February 21, 2022
Investors: Bullnet Capital and CDTI, Centre for the Development of Industrial Technology
Bioherent raised undisclosed on July 26, 2021
Investors: Bullnet Capital